Mechanism of malignant hypercalcaemia in carcinoma of the breast - Wikidata - awgldk - TriplyDB

Mechanism of malignant hypercalcaemia in carcinoma of the breast

Mechanism of malignant hypercalcaemia in carcinoma of the breast

http://www.wikidata.org/entity/Q34488034

about

Hypercalcemia of malignancy revisited.Parathyroid hormone related protein and hypercalcaemia in breast cancer Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents.Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.Skeletal effects of carcinoma of the breast and prostate Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.Hypercalcemia in primary squamous cell carcinoma of the stomach.

P2860

Q34556063-43EB6D5A-F4BA-4D1C-99B1-24C454591F21 Q35181836-5D433ADB-BF0C-4183-9068-7071F5CCF563 Q35587010-F8CB70DF-981E-41C0-AAB1-ABCF06561A55 Q35976111-86F04A6B-6D12-4555-B52B-4785639A8107 Q35978512-D6630CC2-9B10-4236-8777-DFB376C45850 Q36028261-0C1258E1-F19F-4DFB-A27E-F95DA14FFF78 Q36115924-EFBC0B1F-416C-479E-B94B-EC3924DF2C94 Q36815059-DDB3DE77-F703-40CC-9903-68D4FEDE5A65 Q36821023-8CF4F7C4-8017-4890-B037-E38B6C1B2D38 Q55284838-4B848617-1A0C-454D-9B67-228FF487DC04

P2860

Mechanism of malignant hypercalcaemia in carcinoma of the breast

http://www.wikidata.org/entity/Q34488034

description

1985 nî lūn-bûn

@nan

1985 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1985 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1985年の論文

@ja

1985年論文

@yue

1985年論文

@zh-hant

1985年論文

@zh-hk

1985年論文

@zh-mo

1985年論文

@zh-tw

1985年论文

@wuu

name

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@ast

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@en

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@nl

type

label

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@ast

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@en

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@nl

prefLabel

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@ast

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@en

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@nl

P1433

Q34488034-82C6A7A9-604E-478D-B75F-C9C0221A6821

P1476

Q34488034-6F351EF7-E302-4C07-9E12-EBFE60984AB6

P2093

Q34488034-12595033-C231-49BA-BD63-E73FCF20252B

Q34488034-505B83BF-4A9F-4F54-B39B-6144A52F40AB

Q34488034-5DFBAD35-4F51-4E37-B030-B1F6C388FB9D

Q34488034-649F5F44-E5C0-4A6A-9ED4-748CAEE7FA08

Q34488034-9D66DD2F-6DE2-4309-833D-75580D49C8E8

Q34488034-A07412E3-5D95-478D-AE0A-AB3571A5040D

Q34488034-BBA476C3-46DC-4185-81D3-902456C3AB22

P2860

Q34488034-0EE11144-4FA1-45A2-A704-1258AADD38F0

Q34488034-19E454B8-4C87-442E-9820-A0B808EA2A57

Q34488034-28663143-A7D4-43F4-BE94-623E8BFE95BB

Q34488034-55145774-0D89-4FB9-8048-EB770B9209E2

Q34488034-7C88285D-E197-49D2-A27B-4317A98DDC24

Q34488034-822AD385-8DF0-4092-BD88-D09F7732D05F

Q34488034-99E00D00-65C6-4DFF-8CFA-26E5E35D5FA1

Q34488034-A87EF5F9-D260-4D40-BA7D-8821C470AD77

Q34488034-CAD6AA68-D040-4A7A-89A9-912962E81975

Q34488034-CFA9FF46-BC84-4B47-BC97-1CA2C9CB7962

P304

Q34488034-E2707484-D51C-4BA7-90E5-86E78FF575E6

P31

Q34488034-387E4023-006B-429A-8F70-A974D1435BDD

P356

Q34488034-6DCA9CCA-3F17-4BAF-8AE4-1BC047F7855B

P407

Q34488034-B973FE81-BF43-42BA-A96E-B15F2FF3F70B

P433

Q34488034-1A30D846-9158-4FEA-B21C-A0E18A907F8F

P478

Q34488034-931CA685-2C4C-4A54-AC3C-392976A19EAB

P577

Q34488034-D85B400F-E049-454A-9E89-7BDD027ED92E

P698

Q34488034-5EBA5E02-2A84-4D7F-8045-B5EB891DECA1

P932

Q34488034-6ACD56B7-BB7A-4306-8214-13077413C498

P356

BMJ.291.6498.776

P1433

P1476

Mechanism of malignant hypercalcaemia in carcinoma of the breast

@en

P2093

A J Yates

http://www.w3.org/2001/XMLSchema#string

F E Neal

http://www.w3.org/2001/XMLSchema#string

J A Kanis

http://www.w3.org/2001/XMLSchema#string

J Galloway

http://www.w3.org/2001/XMLSchema#string

K Rogers

http://www.w3.org/2001/XMLSchema#string

R C Percival

http://www.w3.org/2001/XMLSchema#string

R E Gray

http://www.w3.org/2001/XMLSchema#string

P2860

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

Treatment of malignant hypercalcaemia with clodronate.

Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.

Nomogram for derivation of renal threshold phosphate concentration.

Determination of hydroxyproline.

The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.

Effects of weight loss on serum 1,25-(OH)2-vitamin D concentrations in adults: a preliminary report.

The hypercalcemia of malignancy: pathogenesis and management.

Tumor hypercalcemia and "ectopic hyperparathyroidism".

Carcinoma of the breast associated with hypercalcemia and the presence of parathyroid hormone-like substances in the tumor.

P304

776-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.291.6498.776

http://www.w3.org/2001/XMLSchema#string

P407

P433

6498

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P577

1985-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3929936

http://www.w3.org/2001/XMLSchema#string

P932

1417171

http://www.w3.org/2001/XMLSchema#string